Lawrence O. Klein
2020
In 2020, Lawrence O. Klein earned a total compensation of $3.7M as Chief Operating Officer at CRISPR Therapeutics AG, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $243,600 |
|---|---|
| Option Awards | $2,368,031 |
| Salary | $420,000 |
| Stock Awards | $614,213 |
| Other | $11,400 |
| Total | $3,657,244 |
Klein received $2.4M in option awards, accounting for 65% of the total pay in 2020.
Klein also received $243.6K in non-equity incentive plan, $420K in salary, $614.2K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Lawrence O. Klein's compensation ranked 3,171st out of 13,090 executives tracked by ExecPay. In other words, Klein earned more than 75.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,171 out of 13,090 | 76th |
Division Manufacturing | 1,237 out of 5,620 | 78th |
Major group Chemicals And Allied Products | 469 out of 2,253 | 79th |
Industry group Drugs | 406 out of 1,953 | 79th |
Industry Biological Products, Except Diagnostic Substances | 101 out of 411 | 75th |
Source: SEC filing on April 28, 2021.
Klein's colleagues
We found four more compensation records of executives who worked with Lawrence O. Klein at CRISPR Therapeutics AG in 2020.